Institutional Investment Pitches
Explore thousands of hedge fund pitches, high-conviction equity research memos, and portfolio manager commentary extracted from quarterly letters.
Explore thousands of hedge fund pitches, high-conviction equity research memos, and portfolio manager commentary extracted from quarterly letters.
We purchased Merck KGaA, a leading life science tools company, based on our conviction that a biopharma spending recovery is underway following a prolonged period of inventory destocking and funding constraints. The inflection is...
— Ariel Investments, LLC
Full equity research memos, financial breakdowns, and hedge fund thesis write-ups are reserved for BSD Research ($50/mo) and Pro subscribers.
Already a Research or Pro subscriber? Sign In
Other investors who've written on Merck KGaA
More institutional theses from Ariel Global Fund
T) is an industrial machinery manufacturer whose underlying value is anchored by its position as the world's second-largest producer of chemical mechanical planarization (CMP) tools for semiconductor manufacturing. Initiated as a...
L) is a consumer health and hygiene multinational possessing ubiquitous global brands including Dettol, Lysol, Durex, and Mucinex. Holding a 1.9%...
First Solar ($FSLR) produces advanced thin-film photovoltaic solar modules for utility-scale power projects. Accounting for 2.1%...